Authors/Disclosures
|
Anil K. Nair, MD, FAAN
(Boston Neuropschiatry)
|
No disclosure on file |
|
Edoardo G. Spinelli, MD
|
Dr. Spinelli has nothing to disclose. |
|
|
No disclosure on file |
|
Anna D. Hohler, MD, FAAN
(Steward SEMC)
|
Dr. Hohler has nothing to disclose. |
|
Samuel A. Frank, MD, FAAN
(Beth Israel Deaconess Medical Center/Harvard Medical School)
|
Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Cerevel. |
|
Margaret Brickley, NP
(Boston University Neurology)
|
No disclosure on file |
|
Georgia D. Montouris, MD
(Boston Univ School of Med/Dept of Neuro)
|
No disclosure on file |
|
Brian E. McGeeney, MD
(Boston University)
|
No disclosure on file |
|
|
No disclosure on file |
|
Alan H. Kurland, MD, FAAN
|
No disclosure on file |